Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
01/2006
01/19/2006US20060014870 Blending a rubber, an inorganic filler, and an acylthio propylenesilane compounds, coupling with rubber and inorganic fillers, deblocking the silane compound and curing the rubber; no odor, for use in tires, shoe soles
01/19/2006US20060014739 Androgen receptor modulators and method of treating disease using the same
01/19/2006US20060014731 Analogs of benzoquinone-containing ansamycins and methods of use thereof
01/19/2006US20060014726 Derivatives of cyclic1, 3- propanediol phosphate and their action in differentiation therapy
01/19/2006US20060014652 Low-phosphorous lubricant additive
01/19/2006US20060014635 Oxysulfonylalkyl phosphonates; monophosphorization and dehalogenation of a dihalohydrocarbon, sulfonation of the remaining halogen, acidification, gelation; curing agents or catalysts for mineral oxides or polysiloxanes; improved stability and homogeneity
01/19/2006US20060013943 tethered amine tantalum complexes for forming barrier layer on microelectronic device; useful in depositing tantalum nitride or tantalum oxides
01/19/2006US20060013860 Anticancer agents; side effect reduction
01/19/2006CA2573396A1 Improved process for the preparation of oxidized phospholipids
01/18/2006EP1616034A2 Acyl- phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis
01/18/2006EP1616025A2 Fluorescent substrates for detecting organophosphatase enzyme activity
01/18/2006EP1615937A2 Analogs of lysophosphatidic acid and methods of making and using thereof
01/18/2006EP1615936A1 Phosphates of secondary alcohols
01/18/2006EP1615935A1 Phosphate derivatives
01/18/2006EP1615650A1 Phosphate derivatives of pharmaceutical products
01/18/2006EP1470138B1 Mmp inhibitors
01/18/2006EP1268096B1 Extrusion die
01/18/2006EP1210327B1 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
01/18/2006CN1723067A Process for catalyst recovery from hydrocyanation product mixtures
01/18/2006CN1721423A Process for synthesis of melamine salt of pentaerythritol bis (dihydrogen phosphate)
01/18/2006CN1721422A Process for preparing PMIDA
01/18/2006CN1721205A Reusable printing plate
01/18/2006CN1720913A Water-soluble triazole fungicide
01/18/2006CN1237067C Preparation of phosphoric acid
01/17/2006US6987202 Phosphine compounds, transition metal complexes with the compounds contained as ligands therein, and asymmetric synthesis catalysts containing the complexes
01/17/2006US6987120 Pharmaceutical compounds
01/17/2006US6987092 Indigoid bisindole derivatives
01/17/2006US6987091 Sir2 products and activities
01/12/2006WO2006004935A2 Pegylated cardiolipin analogs, methods of synthesis, and uses thereof
01/12/2006WO2006003902A1 Novel supported phosphazene catalysts, novel compounds for the catalysts, and use thereof
01/12/2006WO2006003431A1 Monodonor phosphonite ligands
01/12/2006WO2006003295A1 Method for hydroxymethylation of a phosphonic acid in an esterified form
01/12/2006WO2006002875A1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents
01/12/2006WO2006002874A1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain 1, 4, 7, 10-tertraazacyclodecan-1, 4, 7-triacetic acid chelating moiety with polyhydroxylated substituents
01/12/2006WO2006002873A2 1 , 4 -bis (carboxymethyl) -6- ' bis ( carboxymethyl) amino ! -6 -methyl- perhydro-1 , 4 diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri )
01/12/2006WO2006002731A1 Process for the preparation of asymmetrically substituted biaryldiphosphines
01/12/2006WO2006002730A1 Process for the preparation of asymmetrically substituted biaryldiphosphines
01/12/2006WO2006002729A1 Process for the preparation of asymmetrically substituted biaryldiphosphines
01/12/2006WO2005117908A3 Triheterocyclic compounds compositions, and methods for treating cancer or viral diseases
01/12/2006WO2005086961A3 Improved preparation of halohydroccarbyl phosphonic acid diestres
01/12/2006US20060009654 Methods for synthesizing phosphonic compounds and compounds thereof
01/12/2006US20060009646 Novel organic molecular catalyst having binaphthol skeketon and processes for producing the same and application thereof
01/12/2006US20060009624 Phosphoramidites of substituted cyclic (cyclopentene, cyclohexene, and cyclohepene) bridged cyanine dyes, particularly those containing a N,N-diisopropyl-O- beta -cyanoethyl phosphoramidite group; preparation and use in labeling oligonucleotides, proteins and peptides
01/12/2006US20060009507 LPA receptor agonists and antagonists and methods of use
01/12/2006US20060009488 Prodrugs of selective androgen receptor modulators and methods of use thereof
01/12/2006US20060009462 Prodrugs of CC-1065 analogs
01/12/2006US20060008910 stable nucleic acid-lipid particles (SNALP)
01/12/2006US20060008518 Useful for more effective resolution of the mechanism of sphingomyelinase
01/12/2006US20060008417 Lipophilic derivatives of chelate monoamides
01/12/2006DE102004029811A1 Verfahren zur Herstellung von Alkenen durch Eliminierung von Wasser aus Alkoholen mit Alkylphosphonsäureanhydriden Process for the preparation of alkenes by elimination of water from alcohols having alkylphosphonic
01/12/2006DE102004029698A1 Metallkomplexe von 2-Amino- und 2-Hydroxy-2-phosphinoalkansäure-Derivaten, Verfahren zur Herstellung dieser Metallkomplexe und deren Verwendung als Katalysatoren zur Oligomerisation bzw. Polymerisation von Olefinen Metal complexes of 2-amino and 2-hydroxy-2-phosphinoalkansäure derivatives, processes for preparing these metal complexes and their use as catalysts for oligomerization and polymerization of olefins
01/12/2006DE102004029697A1 2-Amino- und 2-Hydroxy-2-phosphinoalkansäure-Derivate und 2-Phosphoniobis(2-hydroxyalkansäure)-Derivate, Verfahren zur Herstellung dieser Derivate und Verwendung der Derivate zur Herstellung von Metallkatalysatoren 2-amino and 2-hydroxy-2-phosphinoalkansäure derivatives and 2-Phosphoniobis (2-hydroxyalkanoic acid) derivatives, processes for preparing these derivatives and use of the derivatives for the preparation of metal catalysts
01/11/2006EP1613665A1 Supported metallocene catalysts
01/11/2006EP1613638A2 Method for producing acylphosphine oxide solids
01/11/2006CN1720252A Transition metal complex having diphosphine complex as ligand
01/11/2006CN1720217A Carbonylation of vinyl acetate
01/11/2006CN1718582A Preparation method of chloramine phos
01/11/2006CN1718581A Preparation method of biothion
01/11/2006CN1235890C Thizaolyl amide derivatives
01/10/2006US6984754 Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents
01/10/2006US6984752 comprises hydrolysis of vinylphosphonic acid ester in presence of carbonyl compound; acid catalysts
01/10/2006US6984744 Phosphine ligands
01/10/2006US6984716 Phosphorus-containing compound
01/10/2006US6984636 Mitochondrially targeted antioxidants
01/10/2006US6984604 Supported bis(phosphorus) ligands and their use in the catalysis
01/10/2006US6984396 Conjugate having a cleavable linkage for use in a liposome
01/10/2006CA2485556C Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
01/10/2006CA2257161C Fungicidal compositions
01/10/2006CA2129897C Coa-it and paf inhibitors
01/06/2006WO2006057384A1 Phosphorylcholine group-containing compound and method for producing same
01/05/2006WO2006002348A2 Solid and crystalline ibandronic acid
01/05/2006WO2006001511A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
01/05/2006WO2004092707A3 Aromatic phosphonium salts and their use as labeling reagents mass spectrometry analysis
01/05/2006US20060004069 Agent for preventing or treating neuropathy
01/05/2006US20060002857 diagnostic detection of diseases accompanied with an abnormality of calcium hydroxyapatite using in vivo imaging; contrast agent comprising a fluorescent moiety covalently linked to a bisphosphonate moiety such as, alendronate, clodronate, EB-1053, etidronate, ibandronate, incadronate, neridronate
01/05/2006DE102004029273A1 Vanadium-amido-Komplexe für die Olefinpolymerisation Vanadium-amido complexes for olefin polymerization
01/05/2006CA2572170A1 Method for producing aromatic compound polymer
01/05/2006CA2571433A1 Solid and crystalline ibandronic acid
01/05/2006CA2571309A1 Chemical compounds
01/05/2006CA2568804A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
01/04/2006EP1612212A1 Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
01/04/2006EP1611145A2 Asymmetric catalysts prepared from optically active bisphosphites bridged by achiral diols
01/04/2006EP1611144A1 Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl phosphonic acid and their use as n-methyl-d-aspartate (nmda) recetor antagonists
01/04/2006EP1611143A2 New carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them
01/04/2006EP1611142A1 Phosphite reactions in the presence of metal soaps for liquid stabilisers
01/04/2006EP1611136A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
01/04/2006EP1611114A2 Amine-substituted diphenyldiphosphines
01/04/2006EP1610894A1 Process for the preparation of a nickel/phosphorous ligand catalyst
01/04/2006EP1169298B1 Pharmaceutical compounds
01/04/2006CN1717410A Bidentate C, P chiral phosphine ligands
01/04/2006CN1234714C Method for producing chlorpyrifos
01/04/2006CN1234713C Process of extracting phosphatidylcholine from soybean phosphatide
01/04/2006CN1234708C Novel imidazotriazinones and the use thereof
01/03/2006US6982336 1,2-dioxetane derivatives, luminescent reagents, luminescence methods and measuring methods
01/03/2006US6981998 Flame-retardant compositions of methanephosphonic acid, boric acid and an organic base
01/03/2006CA2383203C Ligands and asymmetric catalysts made by using the same
01/03/2006CA2244695C Cyclic amic acid derivatives
01/03/2006CA2187146C 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e]-[1,4]- diazepines and their use in the prevention or treatment of hiv infection
01/03/2006CA2156289C Drug composition containing nucleic acid copolymer
01/03/2006CA2136622C Phosphotriester-type biologically active compounds